🇰🇷 Emcyt in South Korea

MFDS authorised Emcyt on 24 December 1981

Marketing authorisation

MFDS — authorised 24 December 1981

  • Marketing authorisation holder: PHARMACIA AND UPJOHN
  • Status: likely_approved

Emcyt in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Emcyt approved in South Korea?

Yes. MFDS authorised it on 24 December 1981.

Who is the marketing authorisation holder for Emcyt in South Korea?

PHARMACIA AND UPJOHN holds the South Korean marketing authorisation.